A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension
E
Elizabeth Martin
Primary Investigator
Overview
Glaucoma treatment study
Description
This study is evaluating the duration and safety of a topical medication (Bimatoprost SR) for people who have OAG or OHT.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
eye,eyes,vision,glaucoma,open-angle glaucoma,ocular hypertension,OAG,POAG,OHT,1904606314
-
Age: Between 18 Years - 100 Years
-
Gender: All
Eligibility Criteria
Diagnosis of either OAG (ie, primary OAG, pseudoexfoliation glaucoma,
pigmentary glaucoma) or OHT in the study eye, requiring IOP-lowering treatment
pigmentary glaucoma) or OHT in the study eye, requiring IOP-lowering treatment
Exclusion Criteria
Previous glaucoma eye surgery
Additional Information:
Updated on
25 Apr 2024.
Study ID: 1904606314